Related Experiment Videos

The vibrio pathogenicity island-encoded mop protein modulates the pathogenesis and reactogenicity of epidemic vibrio

Dalin Zhang1, Zheng Xu, Weiyun Sun

  • 1Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

Infection and Immunity
|December 24, 2002
PubMed

Insights

A newly identified Vibrio cholerae protein, Mop (modulation of pathogenesis), acts as a zinc metalloprotease. This protein modulates cholera

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Vibrio cholerae, the causative agent of cholera, possesses the Vibrio pathogenicity island (VPI).
  • The VPI gene cluster encodes essential virulence factors, including 29 potential proteins, some with unknown functions.

Purpose of the Study:

  • To investigate the function of the VPI-encoded Orf4 protein in Vibrio cholerae pathogenesis.
  • To characterize the enzymatic activity and role of Orf4 in disease progression.

Main Methods:

  • Site-directed mutagenesis to create an orf4 deletion mutant and a catalytically inactive mutant.
  • Phenotypic analysis of the mutant strains, including virulence assays in infant mice and rabbit ileal loops.
  • Histological examination of infected tissues.
  • Complementation studies in vivo.

Main Results:

  • The VPI-encoded Orf4 protein is a zinc metalloprotease, now named Mop.
  • A V. cholerae orf4 mutant exhibited hypervirulence in rabbit ileal loops, with increased hemorrhage and inflammation.
  • Histology revealed significant tissue damage, including edema and inflammatory cell infiltration.
  • Complementation with wild-type orf4 restored virulence, while a catalytically inactive mutant did not.

Conclusions:

  • Orf4 (Mop) is a VPI-encoded zinc metalloprotease that modulates Vibrio cholerae pathogenesis and disease reactogenicity.
  • Mop plays a crucial role in the inflammatory response and tissue damage observed during cholera infection.
  • Targeting Mop may offer a novel therapeutic strategy for cholera.

Related Concept Videos